BAK/MCL1 complexes can predict chemotherapy drugs sensitivity in cancer cells
Ebola: Profile of a dreaded killer
15 September 2021Common factors within the gut associated with depression and bipolar disorder
15 September 2021BAK/MCL1 complexes can predict chemotherapy drugs sensitivity in cancer cells
A research team led by Prof. Dai Haiming from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) recently announced the constitutive BAK/MCL1 complexes could predict chemotherapy drugs sensitivity of ovarian cancer. Result has been published in Cell Death & Disease.
